All (n = 110) | Bacterial CAP (n = 17) | Viral CAP (n = 8) | CAP of unknown origin (n = 7) | Bronchitis (n = 78) | p-value | |
---|---|---|---|---|---|---|
Age, years | 29 (23–39) | 28 (24–35) | 31 (29–51) | 33 (32–64) | 29 (21–38) | 0.051 |
Female sex | 58 (53) | 8 (47) | 3 (38) | 2 (29) | 45 (58) | 0.338 |
HIV-1infection | 36 (33) | 13 (76) | 4 (50) | 1 (14) | 18 (23) | 0.000 |
Co-infection | 22 (20) | 2 (12) | 1 (13) | 1 (14) | 18 (23) | 0.658 |
- Malaria | 7 (6.4) | 1 (5.9) | 0 (0) | 0 (0) | 6 (7.7) | 0.739 |
- Dengue | 7 (6.4) | 0 (0) | 0 (0) | 0 (0) | 7 (9.0) | 0.381 |
- Other | 9 (8.2)a | 1 (5.9) | 1 (13) | 1 (14) | 6 (7.7) | 0.875 |
Sepsis / septic shockb | 27 (25) | 5 (35) | 1 (13) | 1 (14) | 20 (26) | 0.731 |
Symptoms and signs | ||||||
Cough | 103 (94) | 17 (100) | 8 (100) | 6 (86) | 72 (92) | 0.446 |
Dyspnoea | 27 (25) | 6 (35) | 1 (13) | 2 (29) | 18 (23) | 0.606 |
Chest pain, | 25 (23) | 4 (24) | 3 (38) | 2 (29) | 16 (21) | 0.716 |
Respiratory rate, /min | 25 (23–29) | 34 (26–37) | 26 (25–34) | 24 (23–26) | 24 (22–26) | 0.000 |
Abnormal auscultation | 29 (26) | 8 (47) | 2 (25) | 2 (29) | 17 (22) | 0.202 |
Saturation, % | 97 (96–98) | 95 (93–96) | 96 (94–96) | 97 (96–98) | 97 (96–98) | 0.000 |
Systolic BP, mmHg | 117 (104–123) | 100 (97–107) | 119 (109–123) | 126 (120–132) | 118 (104–124) | 0.000 |
Heart rate, /min | 108 (92–120) | 129 (117–138) | 115 (104–120) | 98 (82–108) | 106 (89–115) | 0.000 |
Pneumonia clinical scores | ||||||
CRB-65 scorec ≥ 2 | 12 (11) | 5 (29) | 1 (13) | 0 (0) | 6 (7.7) | 0.053 |
Van Vugt-scored, high | 68 (62) | 16 (94) | 6 (75) | 4 (57) | 42 (54) | 0.016 |
Management and outcome | ||||||
Admission | 20 (18) | 7 (41) | 2 (25) | 2 (29) | 9 (12) | 0.028 |
Antibiotic prescription | 55 (50) | 16 (94) | 7 (88) | 4 (57) | 28 (36) | 0.000 |
28-day mortality | 6 (5.5) | 2 (12) | 1 (13) | 0 (0) | 3 (3.9) | 0.411 |